We are proud that the PNOĒ device was used in a first-of-its-kind study looking into the metabolic changes responsible for weight gain in patients suffering from myelofibrosis. You can read about the research here 👉https://t.co/pG56LdZWif #pnoe #research
520 followers
2,245 followers
Energy expenditure in myelofibrosis patients treated with a JAK1/2 inhibitor https://t.co/QynTds0XeL https://t.co/BRvwVOMRHO
4,897 followers
New Research: Energy expenditure in myelofibrosis patients treated with a JAK1/2 inhibitor: Weight gain is a known adverse effect of ruxolitinib, a JAK1/2 inhibitor that is the mainstay of treatment for many patients with… #Endocrinology #Endo https://t.co